Park Ha Biological Technology (BYAH) Long-Term Deferred Tax (2024 - 2025)

Park Ha Biological Technology (BYAH) recorded quarterly Long-Term Deferred Tax of $83357.0 in Q4 2025, up 48.03% quarter-over-quarter from $56310.0 in Q4 2024, and up 48.03% on a YoY basis from $56310.0 in Q4 2024.

Park Ha Biological Technology (BYAH) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends

Park Ha Biological Technology's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $83357.0 for Q4 2025.

  • In Q4 2025, Long-Term Deferred Tax rose 48.03% year-over-year to $83357.0; the TTM figure through Oct 2025 stood at $83357.0 (up 48.03% YoY), while the FY2025 annual figure was $83357.0, up 48.03% from the prior year.
  • Long-Term Deferred Tax was $83357.0 for Q4 2025 at Park Ha Biological Technology, up from $56310.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $83357.0 in Q4 2025 to a low of $56310.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Tantech Holdings 587.03 Bn 587.00 Bn -
2 Procter & Gamble 346.82 Bn 334.74 Bn 10.51 Bn
3 Unilever 145.94 Bn 135.46 Bn -
4 Colgate Palmolive 70.39 Bn 69.40 Bn 3.23 Bn
5 Kenvue 34.34 Bn 34.23 Bn 2.30 Bn
6 Kimberly Clark 33.38 Bn 32.96 Bn 1.53 Bn
7 Estee Lauder Companies 31.47 Bn 28.34 Bn 2.84 Bn
8 Church & Dwight 22.92 Bn 22.42 Bn 681.40 Mn
9 Clorox 11.90 Bn 10.87 Bn 722.00 Mn
10 Park Ha Biological Technology 912,742.27 -2.87 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2025 83,357.00
Oct 31, 2024 56,310.00